Augmentin drug not allowed in Vn market

The Vietnam Drug Administration (VDA) has ordered its sub-divisions to test the UK-manufactured Augmentin powder for syrup 156mg/5ml (HK-24658) after traces of DIDP were found in tests in Taiwan (China) and Hong Kong.

Middlesex-registered GlaxoSmithKline is the latest corporation and the biggest so far to get embroiled in the Taiwan-originated scare involving plastic additives in food and drugs. The company has been asked to test all its products in Vietnam.

VDA chief Truong Quoc Cuong said Chineses Taiwan and Hong Kong health authorities had ordered GlaxoSmithKline to recall the antibiotic manufactured in France and the UK for paediatric patients, as a plasticiser, Diisodecyl phthalate (DIDP) and Diisononyl phthalate (DINP) were detected in the drugs.

Vietnam has not permitted the sale of the two drugs in the country even though Augmentin powder for syrup 457mg/5ml made in the UK has been issued a registered number. 

By Lien Chau - Translated by Nhat Lam

Other news